Back
Merck KGaA Vs. Affimed NV Industry Stock Comparison
Sell
30
MKGAF
Merck KGaA
Last Price:
175.59
Seasonality Move:
4.34%
Sell
42
AFMD
Affimed NV
Last Price:
5.35
Seasonality Move:
3.52%
Sell
30
Merck KGaA (MKGAF)
is a Sell
Is Merck KGaA a Buy, Sell or Hold?
- The current Merck KGaA [MKGAF] share price is $172.81. The Score for MKGAF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- MKGAF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Affimed NV (AFMD)
is a Sell
Is Affimed NV a Buy, Sell or Hold?
- The current Affimed NV [AFMD] share price is $5.24. The Score for AFMD is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- AFMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MKGAF Stock Price Chart
What is Merck KGaA's stock price today?
-
The Merck KGaA share price today is $172.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MKGAF is experiencing buying pressure, which is a positive indicator for future bullish movement.
AFMD Stock Price Chart
What is Affimed NV's stock price today?
-
The Affimed NV share price today is $5.24
The current trend is relatively stagnant and AFMD is experiencing buying pressure, which is a positive indicator for future bullish movement.
MKGAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.77 | Buy |
| Relative Strength Index (14 RSI): | 58.39 | Buy |
| Chaikin Money Flow: | 176 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (157.97 - 166.45) | Buy |
| Bollinger Bands (100): | (158.25 - 171.29) | Buy |
AFMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 46.5 | Sell |
| Chaikin Money Flow: | 17920 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.06 - 5.56) | Sell |
| Bollinger Bands (100): | (5 - 6.18) | Sell |
MKGAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.23 | Buy |
| 20-day SMA: | 162.05 | Buy |
| 50-day SMA: | 167.1 | Buy |
| 200-day SMA: | 165.59 | Buy |
| 8-day EMA: | 166.46 | Buy |
| 20-day EMA: | 164.53 | Buy |
| 50-day EMA: | 165.12 | Buy |
| 200-day EMA: | 167.24 | Buy |
AFMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.29 | Sell |
| 20-day SMA: | 5.22 | Buy |
| 50-day SMA: | 5.45 | Sell |
| 200-day SMA: | 5.09 | Buy |
| 8-day EMA: | 5.27 | Sell |
| 20-day EMA: | 5.32 | Sell |
| 50-day EMA: | 5.42 | Sell |
| 200-day EMA: | 6.26 | Sell |
Merck KGaA Earnings Growth & MKGAF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Affimed NV Earnings Growth & AFMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, an increase next quarter of $0.60 per share, an increase this year of $2.95 per share, and an increase next year of $1.11 per share.
Merck KGaA Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Affimed NV Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||